Clinical Characteristics of Anti- N-Methyl-d-Aspartate Receptor Encephalitis Overlapping with Demyelinating Diseases: A Review
- PMID: 35837405
- PMCID: PMC9273846
- DOI: 10.3389/fimmu.2022.857443
Clinical Characteristics of Anti- N-Methyl-d-Aspartate Receptor Encephalitis Overlapping with Demyelinating Diseases: A Review
Abstract
Anti-N-methyl-d-aspartate receptor encephalitis (NMDARe), a common autoimmune encephalitis, can be accompanied by demyelinating disorders, including multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). To compare the clinical characteristics of patients with different overlapping syndromes, we searched the PubMed database and performed a systematic review. Of the 79 patients with overlapping syndromes, 15 had MS, 18 had aquaporin-4-antibody-positive NMOSD (AQP4-Ab-positive NMOSD), and 46 had MOGAD. Compared with classical NMDARe, overlapping syndromes showed atypical symptoms, such as limb weakness, sensory disturbance, and visual impairments in addition to the main symptoms of NMDARe and a lower ratio of ovarian teratoma. Patients with MOGAD overlap were the youngest, while patients with MS and AQP4-Ab-positive NMOSD overlap tended to be older than patients with classical NMDARe. A majority of patients with NMDARe who overlapped with MS or AQP4-Ab-positive NMOSD were female, but this was not the case for patients overlapped with MOGAD. When NMDARe and demyelinating diseases occurred sequentially, the interval was the longest in patients with NMDARe overlapped with MS. A favorable outcome was observed in patients overlapping with MOGAD, but no robust comparison can be drawn with the patients overlapping with AQP4-Ab-positive NMOSD and MS regarding the small number of available data. The long-term prognosis of overlapping syndromes needs further investigation.
Keywords: aquaporin-4-antibody-positive neuromyelitis optica spectrum disorder; demyelinating diseases anti-N-methyl-D-aspartate receptor encephalitis; multiple sclerosis; myelin oligodendrocyte glycoprotein antibody-associated disease; overlapping syndromes.
Copyright © 2022 Zhang, Yang, Liu, Li, Li and Zhou.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Nan D, Zhang Y, Han J, Jin T. Clinical Features and Management of Coexisting Anti-N-Methyl-D-Aspartate Receptor Encephalitis and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis: A Case Report and Review of the Literature. Neurol Sci (2021) 42:847–55. doi: 10.1007/s10072-020-04942-0 - DOI - PubMed
-
- Fan S, Xu Y, Ren H, Guan H, Feng F, Gao X, et al. Comparison of Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Disease and AQP4-IgG-Positive Neuromyelitis Optica Spectrum Disorder (NMOSD) When They Co-Exist With Anti-NMDA (N-Methyl-D-Aspartate) Receptor Encephalitis. Mult Scler Relat Disord (2018) 20:144–52. doi: 10.1016/j.msard.2018.01.007 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
